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Abstract
Background: To examine whether prenatal exposure to parental type 1 diabetes, type 2 diabetes, or gestational diabetes is
associated with an increased risk of malignant neoplasm or diseases of the circulatory system in the offspring.
Methods/Principal Findings: We conducted a population-based cohort study of 1,781,576 singletons born in Denmark from
1977 to 2008. Children were followed for up to 30 years from the day of birth until the onset of the outcomes under study,
death, emigration, or December 31, 2009, whichever came first. We used Cox proportional hazards model to estimate
hazard ratios (HR) with 95% confidence intervals (95% CI) for the outcomes under study while adjusting for potential
confounders. An increased risk of malignant neoplasm was found in children prenatally exposed to maternal type 2 diabetes
(HR=2.2, 95%CI: 1.5–3.2). An increased risk of diseases of the circulatory system was found in children exposed to maternal
type 1 diabetes (HR=2.2, 95%CI: 1.6–3.0), type 2 diabetes (HR=1.4, 95%CI: 1.1–1.7), and gestational diabetes (HR=1.3,
95%CI: 1.1–1.6), but results were attenuated after excluding children with congenital malformations. An increased risk of
diseases of the circulatory system was also found in children exposed to paternal type 2 diabetes (HR=1.5, 95%CI: 1.1–2.2)
and the elevated risk remained after excluding children with congenital malformations.
Conclusions: This study suggests that susceptibility to malignant neoplasm is modified partly by fetal programming.
Diseases of the circulatory system may be modified by genetic factors, other time-stable family factors, or fetal
programming.
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Introduction
The number of pregnant women with diabetes is increasing as a
result of an increasing prevalence of diabetes, a higher age at the
time of birth, and earlier onset of diabetes. [1,2] The health
consequences for their children are only partly known. Children
born to mothers with diabetes have increased perinatal morbidity
and mortality, [3,4] and more often have early markers of
cardiovascular disease [5–7] such as insulin resistance. [6] They
have a higher birth weight [8] which has been associated with an
increased risk of a variety of cancers.[9–12] We hypothesized that
mothers with diabetes may have children with an increased
susceptibility to malignant neoplasm and disease of the circulatory
system. Both genetic factors as well as the diabetic intrauterine
environment shape disease susceptibility in the offspring. [13].
We therefore conducted a population-based cohort study of 1.7
million children who were followed for up to 30 years to examine
whether children born to mothers or fathers with diabetes are
more susceptible to malignant neoplasms or diseases of the
circulatory system. If parental diabetes affects the outcomes in the
offspring mainly through changes in the intrauterine environment,
one would expect only maternal diabetes but not paternal diabetes
to be associated with the outcomes. If mainly time stable family
conditions including genetic factors play a role, one would expect
to see both maternal diabetes and paternal diabetes to be
associated with the outcomes.
Methods
Ethics Statement
According to Danish laws, register-based studies do not need to
obtain consents from individuals, when personal identifiers have
been encrypted and stored by a trusted third part (Statistic
Denmark). The data recruitment was approved by the Danish
Data Protection Agency (J.nr.2008-41-2680).
Study Design, Participants, Exposure, and Outcomes
We identified 1,927,343 singletons born in Denmark from 1977
to 2008 in the Danish Medical Birth Register which includes all
births in Denmark since 1973. [14] All persons living in Denmark
are assigned a unique personal identification number (civil
registration number), which enables accurate linkage of personal
data at the individual level. The Danish Civil Registration System
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numbers, but also data on vital status and family structure. [15].
The Danish National Hospital Register holds nationwide data
on all admissions to any Danish hospital since 1977 and on all
outpatient visits since 1995. The information on diabetes was
based on the Danish version of the 8
th revision of the International
Classification of Diseases (ICD-8) from 1977 to 1993, and the 10
th
revision (ICD-10) from 1994 onwards. [16] All patients with type 1
diabetes or type 2 diabetes were recoded with the same code (ICD-
8: 250) between 1977 and 1986 in the Danish version of ICD-8.
From 1987 to 1993, the Danish version of ICD-8 differentiated
between type 1 diabetes (ICD-8: 249) and type 2 diabetes (ICD-
8:250). From 1994 to 2008, the ICD-10 differentiated between
type 1 diabetes (ICD-10: E10, O240), type 2 diabetes (ICD-10:
E11, O241), gestational diabetes (ICD-10: O24?4, O24?9), and
unspecified diabetes (ICD-10: E12, E13, E14, O242, and O243).
We categorized diabetes as unspecified diabetes if the same person
were recorded with two or more different ICD codes of diabetes at
the same time. If the same person was recorded with different
types of diabetes at different times, we categorized diabetes and
starting time according to the first ICD code.
We also extracted information on diabetes from the Danish
National Diabetes Register that aims at including persons with
diabetes who were only treated outside the hospital. The Danish
National Diabetes Register holds information on diabetes in the
Danish population from 1 January 1995 to 1 January 2007 and it
is based on existing registers including the Danish National
Hospital Register, the National Health Insurance Service Registry,
and the Register of Medicinal Product Statistics. [1,17] The
Danish National Diabetes Register, however, does not differentiate
between type 1 diabetes and type 2 diabetes and the register does
not include gestational diabetes. [1,17] We assume that persons
with diabetes entirely treated outside the hospital were more likely
to have type 2 diabetes, thus any additional diabetes from the
Danish National Diabetes Register were categorized as type 2
diabetes.
Children were classified as prenatally exposed to maternal (or
paternal) diabetes if they were born after the time when their
mothers (or fathers) were recorded with diabetes. Firstly, exposed
children born from 1987 to 1993 were categorized as exposed to
type 1 or type 2 diabetes at the time of birth. Secondly, Exposed
children born from 1994 to 2008 were categorized as exposed to
type 1, type 2, or gestational diabetes at the time of birth. Finally,
any types of diabetes were grouped in a single category and all
exposed children born from 1977 to 2008 and were categorized as
exposed to maternal (or paternal) diabetes regardless of types of
diabetes.
Information on the outcomes of interest was obtained from the
Danish National Hospital Register. Malignant neoplasm were
identified as hospitalizations with ICD-8 (140–209) and ICD-10
(C00–C97), diseases of the circulatory system were identified as
hospitalizations with ICD-8 (390–458) and ICD-10 (I00–I99), and
congenital malformations were identified as hospitalizations with
ICD-8 (740-759) and ICD-10 (Q00–Q99).
Information on gestational age, birth weight, maternal age at
birth, and parity was obtained from the Danish Medical Birth
Registry. [14] Information on maternal education and marital
status at the time of birth from 1980 through 2007 was obtained
from Statistics Denmark. We used data from 1980 to substitute
missing values on maternal education and marital status from
1977 to 1979 and data from 2007 to substitute missing values in
2008, which were not yet available at the time of the study. Some
of other missing values on maternal education (or marital status)
were replaced by available information in the closest preceding or
following five (or three years), whichever came first.
Statistical Analysis
The children were followed from the day of birth until the first
hospitalization or first outpatient visit for the outcomes under
study, death, emigration, or December 31, 2009, whichever came
first.
Since some children were born to the same mothers, we used
robust inference for the Cox proportional hazards model to
estimate hazard ratios (HRs) with 95% confidence interval (95%
CI) for hospitalization due to malignant neoplasm, diseases of the
circulatory system, or congenital malformation for children
exposed to maternal or paternal diabetes compared to the cohort
of unexposed children. In Model 1, we adjusted for maternal age
(five years interval), parity (1, 2, 3+), sex of children (boy, girl),
maternal education (low, middle, and high), maternal marital
status (yes, no), and calendar year (1987–1990, 1991–1993, 1994–
1998, 1999–2003, and 2004–2008). In Model 2, we adjusted for
the same variables but excluding children with any congenital
malformations. In Model 3, we not only excluded children with
any congenital malformations but also extended the adjustment to
include gestational age in weeks, birth weight, and birth weight
squared as continuous variables.
The statistical analyses were done using Stata11 (StataCorp,
College station, TX, USA).
Results
In the final study population, children with missing values on
parity, gestational age, birth weight, maternal education, parental
marital status, or paternal diabetes were excluded (Figure 1) and
1,781,576 children remained. In the study population, 1,734
(0.1%), 12,401 (0.7%), and 11,507 (0.7%) singletons were
prenatally exposed to maternal type 1 diabetes, type 2 diabetes,
and gestational diabetes, respectively (Table 1). Pregnant women
with type 2 diabetes or gestational diabetes tended to be older than
pregnant women without diabetes. A higher proportion of
children exposed to maternal diabetes were born preterm
(Table 1). Mean birth weight was higher in children exposed to
maternal type 1 diabetes (3574 g), type 2 diabetes (3568 g), and
gestational diabetes (3583 g) compared to that of children born to
mothers without diabetes (3486 g). Children were followed for 15
years on average and up to 30 years.
The prevalence of congenital malformation was increased in
singletons exposed to maternal type 1 diabetes, maternal type 2
diabetes, and gestational diabetes when compared to unexposed
singletons among singletons born from 1987 to 2008 (Table 2).
This increased prevalence was neither seen in singletons exposed
to paternal type 1 diabetes nor in singletons exposed to paternal
type 2 diabetes (Table 3). The risks did not change much, when
analyses were done among all singletons born from 1977 to 2008
and any types of maternal or paternal diabetes were grouped into
a single category (Table 2 and 3).
An increased risk of malignant neoplasm was found in singletons
exposed to maternal type 2 diabetes compared to unexposed
singletons and the risk remained high after excluding singletons
with congenital malformations. The HRs were attenuated a little
when analyses were done among all singletons exposed to any
types of maternal diabetes (Table 2). A detailed list of ICD codes
and number of malignant neoplasm in children exposed to
maternal (and paternal) diabetes are available in Table S1.
An increased risk for disease of the circulatory system was found
in singletons exposed to maternal type 1 diabetes, maternal type 2
Health Outcomes in Children of Maternal Diabetes
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when children with congenital malformations were excluded
(Table 2). Similar pattern was found when analyses were done
among all singletons and any types of maternal or paternal
diabetes were grouped into a single category (Table 2). An
increased risk for diseases of the circulatory system was also found
in singletons exposed to paternal type 2 diabetes. The risks
remained high even after excluding children with congenital
malformations, but were attenuated when analyses were done
among all singletons and any types of maternal or paternal
diabetes were grouped into a single category (Table 3). A detailed
list of ICD codes and number of disease of the circulatory system
in children exposed to maternal (and paternal) diabetes are
available in Table S2.
Discussion
An increased risk for malignant neoplasm was found in children
prenatally exposed to maternal type 2 diabetes, and the increased
risk remained after excluding children with congenital malforma-
tions. An increased risk of disease of the circulatory system was
found not only in children exposed to maternal diabetes but also in
children exposed to paternal type 2 diabetes.
A higher prevalence of congenital malformations was found in
children prenatally exposed to maternal diabetes, which is in line
with previous studies. [18–23] An increased risk of congenital
malformation, however, was not seen in children prenatally
exposed to paternal diabetes, which indicates that the observed
association between maternal diabetes and congenital malforma-
tions may be due to the changes in intrauterine environment
induced by maternal diabetes rather than genetic factors.
We found an increased risk of malignant neoplasm in children
prenatally exposed to maternal type 2 diabetes and the associa-
tions seemed not to be modified by higher birth weight or preterm
birth since the results did not change much when we adjusted for
these factors. A previous study reported a higher rate of
hospitalization due to neoplasms in children born to mothers
with diabetes (OR=1.64, 95%CI: 1.06–2.54) [24] but this was
related to maternal insulin dependent diabetes. [25] We did not
see an increased risk of malignant neoplasm in children prenatally
Figure 1. Selection of the study population.
doi:10.1371/journal.pone.0036727.g001
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malignant neoplasm later in life may to some extent be
programmed by a suboptimal intrauterine environment associated
with maternal diabetes. The biological mechanism underlying the
association is unknown but there are several possible factors that
could play a role such as maternal and fetal hyperglycemia [4] and
the fetal response to these changes such as hyperinsulinmia. [8]
Medical treatments of diabetes during pregnancy may also play a
Table 1. Characteristics of the study population.
Exposure Unexposed TYPE 1 DIABETES TYPE 2 DIABETES GESTATIONAL DIABETES
N % N % N% N%
1,755,712 98.6 1,743 0.1 12,401 0.7 11,507 0.7
Gender
Boy 901,560 51.4 912 52.3 6,354 51.2 5,992 52.1
Girl 854,152 48.7 831 47.7 6,047 48.8 5,515 47.9
Maternal age
,20 43,122 2.5 29 1.7 168 1.4 50 0.4
20–24 340,376 19.4 243 13.9 1,792 14.5 777 6.8
25–29 671,642 38.3 673 38.6 4,166 33.6 3,008 26.1
30–34 502,165 28.6 553 31.7 4,000 32.3 4,283 37.2
35–39 172,677 9.8 214 12.3 1,834 14.8 2,676 23.3
.=40 25,730 1.5 31 1.8 441 3.6 713 6.2
Parity
1 805,992 45.9 808 46.4 4,298 34.7 4,093 35.6
2 671,117 38.2 651 37.4 5,040 40.6 4,239 36.8
3+ 278,603 15.9 284 16.3 3,063 24.7 3,175 27.6
Gestational week
,32 15,570 0.9 68 3.9 263 2.1 141 1.2
33–36 62,296 3.6 449 25.8 1,549 12.5 862 7.5
37 68,865 3.9 522 30.0 1,874 15.1 1,286 11.2
38 180,318 10.3 466 26.7 2,116 17.1 2,748 23.9
39 343,743 19.6 164 9.4 2,078 16.8 3,023 26.3
40 620,869 35.4 53 3.0 2,582 20.8 2,672 23.2
41 319,005 18.2 17 1.0 1,355 10.9 607 5.3
.=42 145,046 8.3 4 0.2 584 4.7 168 1.5
Maternal education
Low 638,282 36.4 541 31.0 4,707 38.0 4,273 37.1
Middle 560,558 31.9 626 35.9 4,092 33.0 3,488 30.3
High 556,872 31.7 576 33.1 3,602 29.1 3,746 32.6
Marital status
Married 1,081,838 61.6 981 56.3 7,930 64.0 7,538 65.5
Others 673,874 38.4 762 43.7 4,471 36.1 3,969 34.5
Calendar year
1977–1981 220,649 12.6 0 0.0 1,127 9.1 0 0.0
1982–1986 243,977 13.9 0 0.0 1,585 12.8 0 0.0
1987–1990 223,008 12.7 96 5.5 1,287 10.4 0 0.0
1991–1993 183,333 10.4 155 8.9 890 7.2 3 0.0
1994–1998 306,180 17.4 339 19.5 2,125 17.1 2,363 20.5
1999–2003 294,896 16.8 510 29.3 2,727 22.0 3,202 27.8
2004–2008 283,669 16.2 643 36.9 2,660 21.5 5,939 51.6
Paternal diabetes
Unexposed 1,745,515 99.4 1,726 99.0 12,264 98.9 11,314 98.3
TYPE 1 DIABETES 2,971 0.2 3 0.2 27 0.2 46 0.4
TYPE 2 DIABETES 7,039 0.4 14 0.8 108 0.9 139 1.2
doi:10.1371/journal.pone.0036727.t001
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larger studies with longer follow-up time are wanted. Congenital
malformations did not act as a mediator for the observed
associations between maternal diabetes and risk of malignant
neoplasm since the results did not change much when we excluded
children with congenital malformations from the analyses.
Intrauterine exposure to maternal diabetes is associated with
childhood overweight, obesity, metabolic syndrome [26,27], and
type 2 diabetes [28] in the offspring, all of which are risk factors for
diseases of the circulatory system. An increased risk of hyperten-
sion has been reported in offspring of diabetic mothers in humans
[6,29] and animals. [30] We found an overall increased risk of
diseases of the circulatory system, not only in children prenatally
exposed to maternal diabetes, but also in children exposed to
paternal type 2 diabetes, which suggest that genetic or other time-
stable family factors also play a role. However, diseases of the
circulatory system in our study population were, to large extent,
related to congenital abnormalities rather than age-related
cardiovascular diseases, which makes congenital malformations
act as a mediator for the observed associations between maternal
diabetes and risk of disease of the circulatory system. Longer
follow-up time is needed for studies on atherosclerosis, myocardial
infarction, stroke, and cardiovascular death. In addition, the
endpoints in the current study were hospitalizations due to a
category of diseases instead of hospitalizations due to a specific
disease. Thus the observed associations between maternal or
paternal diabetes and disease of the circulatory system may not
apply to specific diseases in the categories.
Although type 1 diabetes and type 2 diabetes have common
features in terms of increased level of glucose, triglycerides, and
many amino acids in the maternal circulation, their genetic
background and ability to modify the intrauterine environment
probably differ. [31] Previous studies suggest that changes in long-
term health outcomes in the offspring of diabetic mothers are not
strongly dependent on the type of maternal diabetes, [28,32,33]
which is supported by some but not all results in the current study.
We used a large population-based cohort including all children
born in Denmark and had up to 30 years of almost complete
Table 2. Hazard ratios (HRs) for different health outcomes according to types of maternal diabetes.
All singletons Singletons with congenital malformations excluded
Person-years (PY)
Number
of cases IR/10
3 PY
Crude
HRs Model 1
a
Number of
cases IR/10
3 PY Model 2
b Model 3
c
Maternal diabetes from 1987 to 2008
Malignant neoplasm
Unexposed 16,835,352 3,318 0.20 2,707 0.18
Type 1 diabetes 16,619 4 0.24 1.2 1.3 (0.5–3.5) 3 0.22 1.3 (0.4–4.2) 1.2 (0.4–3.9)
Type 2 diabetes 68,091 27 0.40 2?0 2.2 (1.5–3.2) 19 0.31 1.9 (1.2–3.1) 1.9 (1.2–3.0)
Gestational diabetes 85,308 10 0.12 0.6 0.7 (0.4–1.3) 8 0.10 0.7 (0.3–1.4) 0.7 (0.3–1.3)
Diseases of the circulatory system
Unexposed 16,743,165 19,235 1.15 14,107 0.93
Type 1 diabetes 16,377 37 2.26 2.3 2.2 (1.6–3.0) 15 1.09 1.4 (0.8–2.3) 1.2 (0.7–2.1)
Type 2 diabetes 67,590 98 1.45 1.5 1.4 (1.1–1.7) 60 0.99 1.3 (1.0–1.6) 1.2 (0.9–1.6)
Gestational diabetes 84,803 113 1.33 1.5 1?3 (1.1–1.6) 70 0.92 1.3 (1.0–1.6) 1.2 (1.0–1.6)
Congenital malformation
Unexposed 15,655,126 121,737 7.78
Type 1 diabetes 14,455 251 17.36 1.8 1.7 (1?5–2?0)
Type 2 diabetes 62,765 680 10.83 1.2 1.6 (1?1–1?3)
Gestational diabetes 78,523 1,125 14.33 1.2 1.2 (1?2–1?3)
Any maternal diabetes (1977–2008)
Malignant neoplasm
2
Unexposed 28,751,460 7,224 0.25 5,935 0.23
All diabetes 283,573 90 0.32 1.4 1.5 (1.2–1?8) 65 0.26 1.4 (1.1–1.7) 1.3 (1.0–1.7)
Diseases of the circulatory system
Unexposed 28,556,453 41,143 1.44 31,994 1.25
All diabetes 280,922 484 1.72 1.5 1.4 (1.3–1.5) 305 1.23 1.2 (1.1–1.4) 1.1 (1.0–1.3)
Congenital malformation
Unexposed 26,628,315 171,729 6.45
All diabetes 256,183 2,911 11.36 1.4 1.3 (1?3–1?4)
aModel 1: Hazard ratios (HRs) were adjusted for maternal age (,20, 20–24, 25–29, 30–34, 35–39, and 40+), parity (1, 2, and 3+), sex (boy and girl), maternal education
(low, middle, and high), maternal marital status (yes or no), calendar year (1977–1981, 1982–1986, 1987–1990, 1991–1993, 1994–1998, 1999–2003, and 2004–2008).
bModel 2: HRs after exclusion of children with congenital malformations and after adjustments for the same variables as that in model 1.
cModel 3: HRs after exclusion o children with congenital malformations and after extended adjustments in the Model 1 by including gestational age at birth as a
continuous variable, birth weight, and square of the birth weight.
doi:10.1371/journal.pone.0036727.t002
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malignant neoplasm, and diseases of the circulatory system is
high since health services, including antenatal care and hospital-
izations, are free of charge for all citizens in Denmark. However,
some women have type 2 diabetes without knowing it [34] and
their children will remain in the unexposed cohort, which would
attenuate the associations slightly. In addition, some misclassifica-
tion between different types of diabetes is likely, [34] especially
between 1987 and 1993. We were able to adjust for a number of
variables in the analyses but unfortunately, we had no data on
lifestyle factors such as maternal smoking, pre-pregnancy body
mass index, or breast-feeding. The observed associations could be
confounded by these factors.
Conclusions
This study suggests that susceptibility to malignant neoplasm
and congenital malformation may be results of fetal programming
induced by maternal diabetes. The risk of disease of circulatory
system may be related to genetic factors or other time stable family
factors as well as fetal programming. Congenital malformation
may act as one of the potential pathways of associations between
diabetic intrauterine environment and risk of diseases of the
circulatory system in children prenatally exposed to maternal
diabetes. We had insufficient follow time to examine risk of
atherosclerosis and other aging related cardiovascular diseases.
Paternal diabetes had no association with congenital malformation
measured as prevalence at birth.
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Table 3. Hazard ratios (HRs) for different health outcomes according to types of paternal diabetes.
All singletons Singletons with congenital malformation excluded
Person-years (PY)
Number of
cases IR/10
3 PY
Crude
HRs Model 1
a
Number of
cases IR/10
3 PY Model 2
b Model 3
c
Paternal diabetes were divided into subtypes (1987–2008)
Malignant neoplasm
Unexposed 17,167,892 3,422 0.20 2,789 0.18
Type 1 diabetes 27,915 6 0.21 1.1 1.2 (0.6–2.8) 5 0.20 1.3 (0.5–3.0) 1.3 (0.5–3.0)
Type 2 diabetes 20,123 3 0.15 0.7 0.8 (0.3–2.6) 2 0.11 0.7 (0.2–2.8) 0.7 (0.2–2.8)
Diseases of the circulatory system
Unexposed 17,073,253 19,799 1.16 14,550 0.94
Type 1 diabetes 27,779 31 1.12 1.2 1.1 (0.8–1.6) 24 0.94 1.2 (0.8–1.9) 1.2 (0.8–1.9)
Type 2 diabetes 19,969 32 1.60 1.7 1.5 (1?1–2?2) 23 1.27 1.6 (1.1–2.5) 1.6 (1.1–2.5)
Congenital malformation
Unexposed 15,964,140 122,947 7.70
Type 1 diabetes 26,232 245 9.34 1.0 1.0 (0?8–1?1)
Type 2 diabetes 18,713 228 12.18 1.2 1.1 (1?0–1?3)
Any paternal diabetes (1977–2008)
Malignant neoplasm
Unexposed 28,751,460 7,224 0.25 5,935 0.23
All diabetes 131,704 29 0.22 1.0 1.0 (0.7–1.5) 24 0.20 1.0 (0.7–1?5) 1.0 (0.7 -1.5)
Diseases of the circulatory system
Unexposed 28,556,453 41,143 1.44 31,994 1.25
All diabetes 130,683 191 1.46 1.3 1.2 (1.0–1.4) 149 1.27 1.2 (1.0–1?4) 1.2 (1.0–1.4)
Congenital malformation
Unexposed 26,628,315 171,729 6.45
All diabees 122,039 973 7.97 1.1 1.0 (1.0–1.1)
aModel 1: Hazard ratios (HRs) were adjusted for maternal age (,20, 20–24, 25–29, 30–34, 35–39, and 40+), parity (1, 2, and 3+), sex (boy and girl), maternal education
(low, middle, and high), maternal marital status (yes or no), calendar year (1977–1981, 1982–1986, 1987–1990, 1991–1993, 1994–1998, 1999–2003, and 2004–2008).
bModel 2: HRs after exclusion of children with congenital malformations and after adjustments for the same variables as that in model 1.
cModel 3: HRs after exclusion of excluding children with congenital malformations and after extended adjustments in the Model 1 by including gestational age at birth
as a continuous variable, birth weight, and square of the birth weight.
doi:10.1371/journal.pone.0036727.t003
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